Vertex Pharmaceuticals (VRTX) Assets (2009 - 2026)
Vertex Pharmaceuticals (VRTX) recorded Assets of $27.42 billion in Q2 2026, up 14.1% from $24.04 billion a year earlier and up 3.5% from the prior quarter.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Assets (2009 - 2026) Analysis & Trends
At the end of FY2025, Vertex Pharmaceuticals reported Assets of $25.64 billion, up 13.8% from FY2024.
- Annual Assets has a five-year compound annual growth rate of 16.9% (FY2020 to FY2025).
- Across earlier years, Assets came in at $22.53 billion in FY2024 (-0.9%), $22.73 billion in FY2023 (+25.2%), $18.15 billion in FY2022 (+35.1%) and $13.43 billion in FY2021 (+14.3%).
- The Q2 2026 figure is the highest quarterly Assets in data going back to Q4 2009.
- On a year-over-year basis, Assets has increased for five consecutive quarters, with growth averaging 9.0% over the last eight quarters.
- Peak year-over-year performance for Assets in the last five years was growth of 35.1% in Q4 2022, against a decline of 4.3% in Q1 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $26.48 billion (Q1 2026), $25.64 billion (Q4 2025) and $24.86 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Vertex Pharmaceuticals | 126.70 Bn | 98.70 Bn | 2.84 Bn | 27.42 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 27.42 Bn |
| Mar 31, 2026 | 26.48 Bn |
| Dec 31, 2025 | 25.64 Bn |
| Sep 30, 2025 | 24.86 Bn |
| Jun 30, 2025 | 24.04 Bn |
| Mar 31, 2025 | 22.88 Bn |
| Dec 31, 2024 | 22.53 Bn |
| Sep 30, 2024 | 22.24 Bn |
| Jun 30, 2024 | 20.13 Bn |
| Mar 31, 2024 | 23.92 Bn |
| Dec 31, 2023 | 22.73 Bn |
| Sep 30, 2023 | 21.73 Bn |
| Jun 30, 2023 | 20.35 Bn |
| Mar 31, 2023 | 18.97 Bn |
| Dec 31, 2022 | 18.15 Bn |
| Sep 30, 2022 | 16.71 Bn |
| Jun 30, 2022 | 15.58 Bn |
| Mar 31, 2022 | 14.26 Bn |
| Dec 31, 2021 | 13.43 Bn |
| Sep 30, 2021 | 12.62 Bn |
API Access
Vertex Pharmaceuticals Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=VRTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "VRTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=VRTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();